Annual Operating Profit
$1.29 B
-$199.71 M-13.38%
December 31, 2024
Summary
- As of March 12, 2025, RPRX annual operating income is $1.29 billion, with the most recent change of -$199.71 million (-13.38%) on December 31, 2024.
- During the last 3 years, RPRX annual operating profit has fallen by -$138.27 million (-9.66%).
- RPRX annual operating profit is now -50.73% below its all-time high of $2.62 billion, reached on December 31, 2019.
Performance
RPRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$361.51 M
-$373.56 M-50.82%
December 31, 2024
Summary
- As of March 12, 2025, RPRX quarterly operating income is $361.51 million, with the most recent change of -$373.56 million (-50.82%) on December 31, 2024.
- Over the past year, RPRX quarterly operating profit has dropped by -$251.38 million (-41.02%).
- RPRX quarterly operating profit is now -72.86% below its all-time high of $1.33 billion, reached on December 31, 2019.
Performance
RPRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$1.29 B
-$251.38 M-16.28%
December 31, 2024
Summary
- As of March 12, 2025, RPRX TTM operating income is $1.29 billion, with the most recent change of -$251.38 million (-16.28%) on December 31, 2024.
- Over the past year, RPRX TTM operating profit has dropped by -$199.71 million (-13.38%).
- RPRX TTM operating profit is now -50.95% below its all-time high of $2.64 billion, reached on June 30, 2020.
Performance
RPRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RPRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.4% | -41.0% | -13.4% |
| 3 y3 years | -9.7% | -41.0% | -13.4% |
| 5 y5 years | -50.7% | -41.0% | -13.4% |
RPRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.4% | +40.0% | -50.8% | +590.0% | -16.3% | +40.0% |
| 5 y | 5-year | -50.7% | +40.0% | -72.9% | +590.0% | -51.0% | +40.0% |
| alltime | all time | -50.7% | +40.0% | -72.9% | +590.0% | -51.0% | +199.9% |
Royalty Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.29 B(-13.4%) | $361.51 M(-50.8%) | $1.29 B(-16.3%) |
| Sep 2024 | - | $735.07 M(+172.6%) | $1.54 B(+60.8%) |
| Jun 2024 | - | $269.63 M(-465.5%) | $960.19 M(+2.2%) |
| Mar 2024 | - | -$73.77 M(-112.0%) | $939.40 M(-37.0%) |
| Dec 2023 | $1.49 B(+61.7%) | $612.90 M(+304.7%) | $1.49 B(+47.4%) |
| Sep 2023 | - | $151.44 M(-39.1%) | $1.01 B(-3.9%) |
| Jun 2023 | - | $248.84 M(-48.0%) | $1.05 B(-10.9%) |
| Mar 2023 | - | $478.97 M(+259.7%) | $1.18 B(+28.1%) |
| Dec 2022 | $922.89 M(-35.5%) | $133.17 M(-30.7%) | $922.89 M(-2.1%) |
| Sep 2022 | - | $192.21 M(-49.1%) | $943.14 M(-10.5%) |
| Jun 2022 | - | $377.79 M(+71.9%) | $1.05 B(-25.8%) |
| Mar 2022 | - | $219.72 M(+43.2%) | $1.42 B(-0.7%) |
| Dec 2021 | $1.43 B | $153.42 M(-49.4%) | $1.43 B(-13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $303.05 M(-59.3%) | $1.66 B(-11.1%) |
| Jun 2021 | - | $744.95 M(+224.9%) | $1.86 B(+22.0%) |
| Mar 2021 | - | $229.30 M(-39.5%) | $1.53 B(-8.0%) |
| Dec 2020 | $1.66 B(-36.7%) | $379.11 M(-25.7%) | $1.66 B(-36.5%) |
| Sep 2020 | - | $510.57 M(+24.7%) | $2.61 B(-0.8%) |
| Jun 2020 | - | $409.35 M(+13.3%) | $2.64 B(+3.2%) |
| Mar 2020 | - | $361.43 M(-72.9%) | $2.55 B(-2.6%) |
| Dec 2019 | $2.62 B(+92.3%) | $1.33 B(+150.1%) | $2.62 B(+103.1%) |
| Sep 2019 | - | $532.50 M(+62.4%) | $1.29 B(+70.2%) |
| Jun 2019 | - | $327.86 M(-23.9%) | $758.76 M(+76.1%) |
| Mar 2019 | - | $430.90 M | $430.90 M |
| Dec 2018 | $1.36 B(+45.2%) | - | - |
| Dec 2017 | $939.69 M | - | - |
FAQ
- What is Royalty Pharma annual operating income?
- What is the all time high annual operating profit for Royalty Pharma?
- What is Royalty Pharma annual operating profit year-on-year change?
- What is Royalty Pharma quarterly operating income?
- What is the all time high quarterly operating profit for Royalty Pharma?
- What is Royalty Pharma quarterly operating profit year-on-year change?
- What is Royalty Pharma TTM operating income?
- What is the all time high TTM operating profit for Royalty Pharma?
- What is Royalty Pharma TTM operating profit year-on-year change?
What is Royalty Pharma annual operating income?
The current annual operating profit of RPRX is $1.29 B
What is the all time high annual operating profit for Royalty Pharma?
Royalty Pharma all-time high annual operating income is $2.62 B
What is Royalty Pharma annual operating profit year-on-year change?
Over the past year, RPRX annual operating income has changed by -$199.71 M (-13.38%)
What is Royalty Pharma quarterly operating income?
The current quarterly operating profit of RPRX is $361.51 M
What is the all time high quarterly operating profit for Royalty Pharma?
Royalty Pharma all-time high quarterly operating income is $1.33 B
What is Royalty Pharma quarterly operating profit year-on-year change?
Over the past year, RPRX quarterly operating income has changed by -$251.38 M (-41.02%)
What is Royalty Pharma TTM operating income?
The current TTM operating profit of RPRX is $1.29 B
What is the all time high TTM operating profit for Royalty Pharma?
Royalty Pharma all-time high TTM operating income is $2.64 B
What is Royalty Pharma TTM operating profit year-on-year change?
Over the past year, RPRX TTM operating income has changed by -$199.71 M (-13.38%)